Werlinich Asset Management, LLC Novo Nordisk A S Transaction History
Werlinich Asset Management, LLC
- $172 Billion
- Q4 2024
A detailed history of Werlinich Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Werlinich Asset Management, LLC holds 12,305 shares of NVO stock, worth $997,074. This represents 0.61% of its overall portfolio holdings.
Number of Shares
12,305Holding current value
$997,074% of portfolio
0.61%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,918Shares Held
318MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.64 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.16 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.16 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.08 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$990 Million3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $183B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...